Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality.
Defendi F, Leroy C, Epaulard O, Clavarino G, Vilotitch A, Le Marechal M, Jacob MC, Raskovalova T, Pernollet M, Le Gouellec A, Bosson JL, Poignard P, Roustit M, Thielens N, Dumestre-Pérard C, Cesbron JY. Defendi F, et al. Among authors: poignard p. Front Immunol. 2021 Sep 10;12:742446. doi: 10.3389/fimmu.2021.742446. eCollection 2021. Front Immunol. 2021. PMID: 34567008 Free PMC article.
Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
Clavarino G, Leroy C, Epaulard O, Raskovalova T, Vilotitch A, Pernollet M, Dumestre-Pérard C, Defendi F, Le Maréchal M, Le Gouellec A, Audoin P, Bosson JL, Poignard P, Roustit M, Jacob MC, Cesbron JY. Clavarino G, et al. Among authors: poignard p. Front Immunol. 2022 Jul 15;13:889813. doi: 10.3389/fimmu.2022.889813. eCollection 2022. Front Immunol. 2022. PMID: 35911748 Free PMC article.
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
Epaulard O, Buisson M, Nemoz B, Maréchal ML, Terzi N, Payen JF, Froidure M, Blanc M, Mounayar AL, Quénard F, Pierre I, Pavese P, Germi R, Grossi L, Larrat S, Poignard P, Lupo J. Epaulard O, et al. Among authors: poignard p. J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.009. Epub 2021 Oct 20. J Infect. 2022. PMID: 34687831 Free PMC article. No abstract available.
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
Truffot A, Andréani J, Le Maréchal M, Caporossi A, Epaulard O, Germi R, Poignard P, Larrat S. Truffot A, et al. Among authors: poignard p. Emerg Infect Dis. 2021 Oct;27(10):2725-2728. doi: 10.3201/eid2710.211509. Epub 2021 Aug 5. Emerg Infect Dis. 2021. PMID: 34352197 Free PMC article.
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Sulbaran G, Maisonnasse P, Amen A, Effantin G, Guilligay D, Dereuddre-Bosquet N, Burger JA, Poniman M, Grobben M, Buisson M, Dergan Dylon S, Naninck T, Lemaître J, Gros W, Gallouët AS, Marlin R, Bouillier C, Contreras V, Relouzat F, Fenel D, Thepaut M, Bally I, Thielens N, Fieschi F, Schoehn G, van der Werf S, van Gils MJ, Sanders RW, Poignard P, Le Grand R, Weissenhorn W. Sulbaran G, et al. Among authors: poignard p. Cell Rep Med. 2022 Jan 24;3(2):100528. doi: 10.1016/j.xcrm.2022.100528. eCollection 2022 Feb 15. Cell Rep Med. 2022. PMID: 35233549 Free PMC article.
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.
Bal A, Brengel-Pesce K, Gaymard A, Quéromès G, Guibert N, Frobert E, Bouscambert M, Trabaud MA, Allantaz-Frager F, Oriol G, Cheynet V, d'Aubarede C, Massardier-Pilonchery A, Buisson M, Lupo J, Pozzetto B, Poignard P, Lina B, Fassier JB, Morfin F, Trouillet-Assant S; COVID-SER Study group. Bal A, et al. Among authors: poignard p. Sci Rep. 2021 Jul 22;11(1):14977. doi: 10.1038/s41598-021-93828-y. Sci Rep. 2021. PMID: 34294751 Free PMC article.
Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform.
Chevillard C, Amen A, Besson S, Hannani D, Bally I, Dettling V, Gout E, Moreau CJ, Buisson M, Gallet S, Fenel D, Vassal-Stermann E, Schoehn G, Poignard P, Dagher MC, Fender P. Chevillard C, et al. Among authors: poignard p. Mol Ther. 2022 May 4;30(5):1913-1925. doi: 10.1016/j.ymthe.2022.02.011. Epub 2022 Feb 10. Mol Ther. 2022. PMID: 35151843 Free PMC article.
Antibody neutralization of HIV-1.
Poignard P, Klasse PJ, Sattentau QJ. Poignard P, et al. Immunol Today. 1996 May;17(5):239-46. doi: 10.1016/0167-5699(96)10007-4. Immunol Today. 1996. PMID: 8991386 Review.
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
McCoy LE, Falkowska E, Doores KJ, Le K, Sok D, van Gils MJ, Euler Z, Burger JA, Seaman MS, Sanders RW, Schuitemaker H, Poignard P, Wrin T, Burton DR. McCoy LE, et al. Among authors: poignard p. PLoS Pathog. 2015 Aug 12;11(8):e1005110. doi: 10.1371/journal.ppat.1005110. eCollection 2015 Aug. PLoS Pathog. 2015. PMID: 26267277 Free PMC article.
104 results